These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 16982058)

  • 21. [The salvage of ischaemic limb by therapeutical angiogenesis].
    Talapková R; Hudecek J; Sinák I; Kubisz P; Laca L; Hlinka L; Zelenák K
    Vnitr Lek; 2009 Mar; 55(3):179-83. PubMed ID: 19378842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Separation of adult bone marrow mononuclear cells using the automated closed separation system Sepax.
    Aktas M; Radke TF; Strauer BE; Wernet P; Kogler G
    Cytotherapy; 2008; 10(2):203-11. PubMed ID: 18368599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Limb salvage using intramuscular injection of unfractionated autologous bone marrow mononuclear cells in critical limb ischemia: a prospective pilot clinical trial.
    Gabr H; Hedayet A; Imam U; Nasser M
    Exp Clin Transplant; 2011 Jun; 9(3):197-202. PubMed ID: 21649569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Local intramuscular transplantation of autologous mononuclear cells for critical lower limb ischaemia.
    Moazzami K; Moazzami B; Roohi A; Nedjat S; Dolmatova E
    Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD008347. PubMed ID: 25525690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomised comparison of G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow-mononuclear cells for the treatment of patients with lower limb arteriosclerosis obliterans.
    Huang PP; Yang XF; Li SZ; Wen JC; Zhang Y; Han ZC
    Thromb Haemost; 2007 Dec; 98(6):1335-42. PubMed ID: 18064333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Therapeutic Angiogenesis Using Autologous Bone Marrow-Derived Mononuclear Cells Implantation in Critical Limb Ischemia With Scleroderma　- Subanalysis of the Long-Term Clinical Outcomes Survey.
    Shoji K; Yanishi K; Yoshimi R; Hamada N; Kondo K; Fujimoto K; Nakajima H; Kuwahara K; Higashi Y; Fukumoto Y; Murohara T; Matoba S;
    Circ J; 2019 Feb; 83(3):662-671. PubMed ID: 30726805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic angiogenesis by autologous bone marrow cell implantation together with allogeneic cultured dermal substitute for intractable ulcers in critical limb ischaemia.
    Mizuno H; Miyamoto M; Shimamoto M; Koike S; Hyakusoku H; Kuroyanagi Y
    J Plast Reconstr Aesthet Surg; 2010 Nov; 63(11):1875-82. PubMed ID: 20060793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Granulocyte colony-stimulating factor improves the efficacy of autologous bone marrow-derived mononuclear cell transplantation treatment for lower limb ischemia.
    Gu Y; Guo L; Guo J; Dardik A; Zhang S; Tong Z; Zhang J; Wang Z
    Int Angiol; 2017 Aug; 36(4):346-353. PubMed ID: 27958690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Long term follow-up on emergent intracoronary autologous bone marrow mononuclear cell transplantation for acute inferior-wall myocardial infarction].
    Huang RC; Yao K; Zou YZ; Ge L; Qian JY; Yang J; Yang S; Niu YH; Li YL; Zhang YQ; Zhang F; Xu SK; Zhang SH; Sun AJ; Ge JB
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(16):1107-10. PubMed ID: 16796836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Local intramuscular transplantation of autologous mononuclear cells for critical lower limb ischaemia.
    Moazzami K; Majdzadeh R; Nedjat S
    Cochrane Database Syst Rev; 2011 Dec; (12):CD008347. PubMed ID: 22161427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transplantation of autologous bone marrow mononuclear cells with VEGF gene improves diabetic critical limb ischaemia.
    Skóra J; Barć P; Pupka A; Dawiskiba T; Korta K; Albert M; Szyber P
    Endokrynol Pol; 2013; 64(2):129-38. PubMed ID: 23653276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term effects of repeated autologous transplantation of bone marrow cells in patients affected by peripheral arterial disease.
    Cobellis G; Silvestroni A; Lillo S; Sica G; Botti C; Maione C; Schiavone V; Rocco S; Brando G; Sica V
    Bone Marrow Transplant; 2008 Nov; 42(10):667-72. PubMed ID: 18695661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Middle-term outcome of autologous bone marrow mononuclear cells transplantation for treatment of lower limb ischemia].
    Gu Y; Qi L; Zhang J; Guo L; Li J; Zhang S; Yu H; Li X; Cui S; Chen B; Wu Y; Tong Z; Wang Z
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2009 Mar; 23(3):341-4. PubMed ID: 19366150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of autologous bone marrow mononuclear cells in six patients with advanced chronic critical limb ischemia as a result of diabetes: our experience.
    Subrammaniyan R; Amalorpavanathan J; Shankar R; Rajkumar M; Baskar S; Manjunath SR; Senthilkumar R; Murugan P; Srinivasan VR; Abraham S
    Cytotherapy; 2011 Sep; 13(8):993-9. PubMed ID: 21671823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autologous bone-marrow mononuclear cell implantation for patients with Rutherford grade II-III thromboangiitis obliterans.
    Durdu S; Akar AR; Arat M; Sancak T; Eren NT; Ozyurda U
    J Vasc Surg; 2006 Oct; 44(4):732-9. PubMed ID: 16926085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autologous bone-marrow mononuclear cell implantation reduces long-term major amputation risk in patients with critical limb ischemia: a comparison of atherosclerotic peripheral arterial disease and Buerger disease.
    Idei N; Soga J; Hata T; Fujii Y; Fujimura N; Mikami S; Maruhashi T; Nishioka K; Hidaka T; Kihara Y; Chowdhury M; Noma K; Taguchi A; Chayama K; Sueda T; Higashi Y
    Circ Cardiovasc Interv; 2011 Feb; 4(1):15-25. PubMed ID: 21205941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination of in vivo angiopoietin-1 gene transfer and autologous bone marrow cell implantation for functional therapeutic angiogenesis.
    Kobayashi K; Kondo T; Inoue N; Aoki M; Mizuno M; Komori K; Yoshida J; Murohara T
    Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1465-72. PubMed ID: 16645159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peripheral blood mononuclear cell transplantation to treat no-option critical limb ischaemia: effectiveness and safety.
    Sermsathanasawadi N; Pruekprasert K; Chruewkamlow N; Kittisares K; Warinpong T; Chinsakchai K; Wongwanit C; Ruangsetakit C; Mutirangura P
    J Wound Care; 2021 Jul; 30(7):562-567. PubMed ID: 34256601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autologous peripheral blood mononuclear cell implantation for patients with peripheral arterial disease improves limb ischemia.
    Ishida A; Ohya Y; Sakuda H; Ohshiro K; Higashiuesato Y; Nakaema M; Matsubara S; Yakabi S; Kakihana A; Ueda M; Miyagi C; Yamane N; Koja K; Komori K; Takishita S
    Circ J; 2005 Oct; 69(10):1260-5. PubMed ID: 16195628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effective concentration of bone marrow mononuclear cells using density gradient separation within an automated cell separator.
    Baker PK; Rhodes EG; Duguid JK
    Transfus Sci; 1992 Jul; 13(3):353-6. PubMed ID: 10148131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.